Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Galectin Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
GALT
Nasdaq
2834
http://www.galectintherapeutics.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Galectin Therapeutics Inc
Blog Exposure - Adamas Pharma Announced Final Results from EASE LID 2 Study Evaluating GOCOVRI in Parkinson’s Disease Patients with Dyskinesia
- Apr 23rd, 2018 5:30 am
Galectin Therapeutics to Present at 2nd Annual NASH Summit 2018
- Apr 18th, 2018 6:00 am
Galectin Therapeutics Late-Breaker Presentation at The International Liver Congress Reinforces and Extends the Positive Effects of GR-MD-02 in Patients With NASH Cirrhosis
- Apr 16th, 2018 6:00 am
Today’s Research Reports on Trending Tickers: Exelixis and Galectin Therapeutics
- Apr 5th, 2018 6:30 am
Galectin Therapeutics to Present Late-Breaker Oral Presentation at The International Liver Congress 2018
- Apr 4th, 2018 7:00 am
Galectin Therapeutics to Present at H.C. Wainwright Global Life Sciences Conference
- Apr 2nd, 2018 8:20 am
These Biotech Stocks Have a Strong Green Close on Friday
- Mar 29th, 2018 4:09 pm
Galectin Therapeutics Reports 2017 Financial Results and Provides Business Update
- Mar 29th, 2018 6:10 am
Galectin Therapeutics to Present at Two International Conferences in March
- Mar 9th, 2018 6:30 am
Galectin Therapeutics to Present at 2nd Annual H.C. Wainwright NASH Investor Conference
- Mar 8th, 2018 6:30 am
Galectin Therapeutics Announces Record Date and Annual Stockholders Meeting Date for 2018
- Mar 5th, 2018 2:00 pm
Galectin Therapeutics to Present at 30th Annual ROTH Conference
- Feb 28th, 2018 2:35 pm
Recent Analysis Shows SBA Communications, AMAG Pharmaceuticals, Galectin Therapeutics, Xilinx, J.B. Hunt Transport Services, and Southern Market Influences — Renewed Outlook, Key Drivers of Growth
- Feb 16th, 2018 6:00 am
Galectin Therapeutics to Present at BIO CEO & Investor Conference
- Feb 6th, 2018 7:15 am
Is Galectin Therapeutics Inc’s (NASDAQ:GALT) CEO Pay Fair?
- Jan 29th, 2018 3:32 am
Galectin Therapeutics Granted Patents in China and Japan that Support NASH and Cancer Immunotherapy Clinical Development Programs
- Jan 25th, 2018 6:30 am
Today’s Research Reports on Trending Tickers: Galectin Therapeutics and Hemispherx BioPharma
- Jan 9th, 2018 6:20 am
Are Options Traders Betting on a Big Move in Galectin Therapeutics (GALT) Stock?
- Jan 4th, 2018 6:40 am
Galectin Therapeutics (GALT) Jumps: Stock Rises 15.1%
- Dec 28th, 2017 6:56 am
Galectin Therapeutics Inc (GALT) Springs Up 18% as Illinois Businessman Pours Millions in Credit to Finance NASH Therapy Development
- Dec 20th, 2017 12:12 pm
Scroll